How Exercise Protects Against Cancer by Maintaining Healthy Muscle

New research published in Nature Communications identifies a biological communication pathway where aging muscle tissue influences tumor development, establishing that regular physical activity can reactivate mechanisms that suppress cancer growth. Scientists from Duke-NUS Medical School, working alongside partners at Singapore General Hospital and Cardiff University, have mapped how sarcopenic muscle—muscle characterized by age-related loss of mass and function—fails to secrete essential protective extracellular vesicles, thereby creating a microenvironment more conducive to malignancy.

Key Clinical Takeaways:

• Muscle-Tumor Signaling: Healthy muscle cells release extracellular vesicles containing miR-7a-5p, a microRNA that regulates gene expression and actively suppresses tumor growth.
• Impact of Sarcopenia: As skeletal muscle mass declines with age, the secretion of these protective vesicles decreases, potentially accelerating cancer progression.
• Exercise as Intervention: Resistance and aerobic exercise can reactivate the biological pathways responsible for the release of these tumor-suppressing particles, offering a targeted approach to cancer risk reduction in older adults.

The Pathogenesis of Sarcopenia and Cancer Risk

The clinical association between low muscle mass and advanced-stage cancer has long been observed in oncology, but the specific molecular mechanism remained opaque. According to the study, muscle cells act as endocrine organs, utilizing extracellular vesicles to transmit signals to other cells. In aged or sarcopenic muscle, these vesicles contain significantly lower concentrations of miR-7a-5p. This microRNA is critical for maintaining genomic stability and controlling protein synthesis that prevents uncontrolled cell proliferation.

Dr. Kenon Chua, a consultant in the orthopedic surgery department at Singapore General Hospital, notes that the loss of healthy muscle tissue is not merely a mobility issue but a systemic health concern. “We observe that healthy muscles secrete many physiologically important molecules. With advanced age, it is even more important to engage in regular resistance and aerobic exercises in order to maintain healthy muscle volume,” Chua stated. This shift in the muscle secretome represents a significant hurdle in geriatric oncology, where maintaining metabolic homeostasis is essential for treatment tolerance and disease prognosis.

Biological Mechanisms of Exercise-Induced Protection

The research team identified a specific biological pathway that governs the release of these extracellular vesicles. While this pathway naturally attenuates with chronological age, the study confirms that physical exertion serves as an exogenous stimulus to restore vesicle secretion. Unlike pharmaceutical interventions that may carry significant contraindications or off-target effects, exercise appears to provide a broad-spectrum, physiological reactivation of this protective signaling.

For clinicians managing aging populations, this underscores the necessity of integrating structured exercise protocols into preventative care. Patients seeking to optimize their physiological resilience should prioritize consultations with board-certified geriatric specialists or physical medicine and rehabilitation centers to ensure that activity levels are both safe and clinically effective for their specific musculoskeletal profile.

Future Directions and Diagnostic Biomarkers

The study was supported by the Singapore Ministry of Education, the Diana Koh Innovative Cancer Research Award, the National Academy of Medicine, and the National Research Foundation, Singapore. The next phase of research will focus on validating these findings in human cohorts to determine if circulating levels of miR-7a-5p can function as a reliable diagnostic biomarker for cancer risk in patients with sarcopenia.

“This study opens new avenues for therapeutic strategies to preserve muscle health and reduce cancer risk, while also underscoring the importance of physical activity in aging,” says Professor Lok Shee Mei, interim vice-dean for research at Duke-NUS Medical School. By establishing a direct link between muscle atrophy and tumor-promoting signaling, researchers are now positioned to develop therapies that mimic or enhance the protective effects of exercise for individuals physically unable to participate in high-intensity training regimens.

Clinical Triage and Management

As the medical community shifts toward personalized longevity medicine, the ability to screen for sarcopenia-related cancer risk may become a standard of care. Identifying early markers of muscle degradation allows for timely intervention, potentially altering the trajectory of disease development. Healthcare providers and oncology centers looking to implement these findings into their standard of care are encouraged to coordinate with specialized diagnostic laboratories to assess the feasibility of tracking microRNA profiles in patients with significant muscle mass loss.

The integration of these findings into clinical practice requires a multidisciplinary approach, combining insights from oncology, gerontology, and exercise physiology. For those managing patients with complex comorbidities, evaluating the patient’s current skeletal muscle index (SMI) via DXA scans remains the gold standard for clinical assessment before designing exercise-based interventions. Future therapeutic developments may involve the synthetic delivery of miR-7a-5p or the pharmacological stimulation of the vesicle-secretion pathway to provide additional support for patients where exercise alone is insufficient to stabilize muscle-to-tumor signaling.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.